PURPOSE: The aim of the study was to determine the actual GJB2 and GJB6 mutation frequencies in North America after several years of generalized testing for autosomal recessive nonsyndromic sensorineural hearing loss to help guide diagnostic testing algorithms, especially in light of molecular diagnostic follow-up to universal newborn hearing screening. METHODS: Mutation types, frequencies, ethnic distributions, and genotype-phenotype correlations for GJB2 and GJB6 were assessed in a very large North American cohort. RESULTS: GJB2 variants were identified in 1796 (24.3%) of the 7401 individuals examined, with 399 (5.4%) homozygous and 429 (5.8%) compound heterozygous. GJB6 deletion testing was performed in 12.0% (888/7401) of all cases. The >300-kb deletion was identified in only nine individuals (1.0%), all of whom were compound heterozygous for mutations in GJB2 and GJB6. Among a total of 139 GJB2 variants identified, 53 (38.1%) were previously unreported, presumably representing novel pathogenic or benign variants. CONCLUSIONS: The frequency and distribution of sequence changes in GJB2 and GJB6 in North America differ from those previously reported, suggesting a considerable role for loci other than GJB2 and GJB6 in the etiology of autosomal recessive nonsyndromic sensorineural hearing loss, with minimal prevalence of the GJB6 deletion.
PURPOSE: The aim of the study was to determine the actual GJB2 and GJB6 mutation frequencies in North America after several years of generalized testing for autosomal recessive nonsyndromic sensorineural hearing loss to help guide diagnostic testing algorithms, especially in light of molecular diagnostic follow-up to universal newborn hearing screening. METHODS: Mutation types, frequencies, ethnic distributions, and genotype-phenotype correlations for GJB2 and GJB6 were assessed in a very large North American cohort. RESULTS: GJB2 variants were identified in 1796 (24.3%) of the 7401 individuals examined, with 399 (5.4%) homozygous and 429 (5.8%) compound heterozygous. GJB6 deletion testing was performed in 12.0% (888/7401) of all cases. The >300-kb deletion was identified in only nine individuals (1.0%), all of whom were compound heterozygous for mutations in GJB2 and GJB6. Among a total of 139 GJB2 variants identified, 53 (38.1%) were previously unreported, presumably representing novel pathogenic or benign variants. CONCLUSIONS: The frequency and distribution of sequence changes in GJB2 and GJB6 in North America differ from those previously reported, suggesting a considerable role for loci other than GJB2 and GJB6 in the etiology of autosomal recessive nonsyndromic sensorineural hearing loss, with minimal prevalence of the GJB6 deletion.
Authors: Hsiao-Yuan Tang; Monica J Basehore; Gregory L Blakey; Sandra Darilek; John S Oghalai; Benjamin B Roa; Ping Fang; Raye Lynn Alford Journal: Am J Med Genet A Date: 2008-04-01 Impact factor: 2.802
Authors: Qianqian Zhu; Dongliang Ge; Erin L Heinzen; Samuel P Dickson; Thomas J Urban; Mingfu Zhu; Jessica M Maia; Min He; Qian Zhao; Kevin V Shianna; David B Goldstein Journal: Am J Hum Genet Date: 2012-08-30 Impact factor: 11.025
Authors: Jerry W Lin; Naweed Chowdhury; Avni Mody; Ross Tonini; Claudia Emery; Jody Haymond; John S Oghalai Journal: Otol Neurotol Date: 2011-02 Impact factor: 2.311
Authors: Kenneth H Lee; Daniel A Larson; Gordon Shott; Brian Rasmussen; Aliza P Cohen; Corning Benton; Mark Halsted; Daniel Choo; Jareen Meinzen-Derr; John H Greinwald Journal: Laryngoscope Date: 2009-03 Impact factor: 3.325
Authors: Margaret A Kenna; Henry A Feldman; Marilyn W Neault; Anna Frangulov; Bai-Lin Wu; Brian Fligor; Heidi L Rehm Journal: Arch Otolaryngol Head Neck Surg Date: 2010-01
Authors: Prachi Kothiyal; Stephanie Cox; Jonathan Ebert; Ammar Husami; Margaret A Kenna; John H Greinwald; Bruce J Aronow; Heidi L Rehm Journal: BMC Biotechnol Date: 2010-02-10 Impact factor: 2.563
Authors: Christopher Beck; Jose Carmelo Pérez-Álvarez; Alexander Sigruener; Frank Haubner; Till Seidler; Charalampos Aslanidis; Jürgen Strutz; Gerd Schmitz Journal: Eur Arch Otorhinolaryngol Date: 2014-09-12 Impact factor: 2.503